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Abstract  
Background. Systemic Lupus Erythematosus (SLE) 
is an autoimmune disease involving many organs 
including the cardiovascular system such as 
accelerated atherosclerosis or premature 
atherosclerosis. Atherosclerotic plaque can cause 
coronary heart disease, ischemic stroke and 
peripheral arterial disease, which are the main 
causes of death in the world. The purpose of this 
study was to determine the prevalence of carotid 
artery atherosclerosis plaques in patients with SLE.  
Method. This research is a descriptive study with a 
cross-sectional design. Carotid artery atherosclerosis 
plaques in SLE patients were assessed by analysing 
results of carotid ultrasound examinations that were 
conducted in 2017-2018. The inclusion criteria of this 
study were SLE patients who had undergone carotid 
doppler ultrasound B mode examination on the 
carotid artery for the period of 2017-2018. The 
exclusion criteria in this study were SLE patients with 
a history of stroke, peripheral arterial disease, and 
significant coronary artery disease.  
Result. This study involved 88 SLE patients who met 
the inclusion criteria. Results showed that there were 
10 SLE patients (11.4%) who had atherosclerotic 
plaques. SLE patients with atherosclerosis plaque 
were mostly in the age range of 35-44 years (16%) 
and 45-54 years (22.2%). There were 2 patients 
(15.3%) with atherosclerotic plaque from a total of 11 
patients had high triglyceride levels (≥150 mg/dL). Chi 
square analysis of lipid profiles (cholesterol, LDL, HDL, 
triglycerides) in patients with atheroclerotic plaque 
revealed not significant (p>0.05). These findings could be 
caused by several factors, such as the small number of 
samples in this study and the non-traditional factors in 
the formation of atherosclerotic plaque as well as other 
traditional factors 
Conclusion. The prevalence of carotid artery 
atherosclerosis plaques in patients with SLE in Dr. 
Hasan Sadikin General Hospital in 2017-2018 is 
11.4%. Keywords : Systemic Lupus Erythematosus, 
Atherosclerotic Plaque, Carotid Artery 
 
 
Introduction  
Systemic lupus erythematosus (SLE) is a systemic 
autoimmune disease, which is characterized by 
extensive inflammation and immune system 
 
 
dysfunction that underlies a set of diverse clinical 
manifestations.1 The clinical manifestations that 
usually occur in patients with SLE ranges from 
constitutional manifestations such as fever and loss of 
appetite, to involve of multiple organs such skin, 
musculoskeletal, renal and brain, including 
cardiovascular. Cardiovascular system manifestations 
usually occur in the form of atherosclerotic plaque.2 
Atherosclerosis is a multifactorial condition that 
involves arteries, characterized by deposit of 
inflammatory cells (macrophages, T lymphocytes), 
extracellular matrix, fat, proteoglycans, 
glycosaminoglycans, connective tissue in the arteries’ 
intima. The process will eventually cause thickening 
and hardening of the artery walls, resulting in arterial 
stiffness and fragility.3,4Atherosclerosis is one of the 
leading causes of death in the world which gives rise 
to coronary heart disease, ischemic heart, ischemic 
stroke, and peripheral arterial disease.5 In SLE 
patients, atherosclerotic plaque can occur in an early 
onset called accelerated atherosclerosis or premature 
atherosclerosis.6 The risk of accelerated 
atherosclerosis or premature atherosclerosis is 
increased in SLE patients five to eight times higher 
than non-SLE patients.7,8 Based on data reported by 
Manzi and colleagues, SLE women aged 35 to 44 
years are 50 times more susceptible to myocardial 
infarction compared with non-SLE women of the 
same age range.9 The European Society of Cardiology 
(ESC) recommended, several options to diagnose 
atherosclerosis, such as Ankle-Brachial Index (ABI) 
and Duplex Ultrasound (DUS). A method of DUS 
called B-mode echography can detect arterial 
subclinical disease including carotid artery plaque 
atherosclerosis.10  
The prevalence of atherosclerosis in SLE 
patients in Indonesia is still unknown, hence a study 
to find out the prevalence of atherosclerosis in SLE 
patients at Dr. Hasan Sadikin General Hospital was 
conducted. This research is expected to help 
provide information of atherosclerosis in SLE and 
further, early detection and complications of 
atherosclerotic plaque in SLE patients could be 
prevented. 
 
Method 
This is a cross-sectional descriptive study and was 
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conducted using secondary data taken in the Rheumatology 
Division of Internal Medicine Dr. Hasan Sadikin Bandung from 
1 January 2017 to 31 December 2018. The subjects of this study 
were patients diagnosed with SLE who were enrolled in previous 
studies entitled “ Atherosclerotic Plaque Correlation with 
Cognitive Disorders in Systemic Lupus Erythematous Patients”. 
The inclusion criteria of this study were SLE patients who had 
undergone carotid Doppler ultrasound B mode on carotid arteries 
from 2017 through 2018. The exclusion criteria were SLE 
patients with a history of significant coronary artery disease 
which includes; (1) history of chest pain typical of angina, having 
a history of heart attack, or currently being treatment for coronary 
artery disease (CAD); (2) having signs of left or right heart failure 
based on physical examination;  
(3) myocardial infarction or ischemic heart disease based on 
electrocardiographic examination. Total sampling was used as 
the sampling method of this study.  
Atherosclerotic plaque was determined by the existence of 
plaque on the left carotid artery, or right carotid artery or both 
as listed on the medical records. The collected data was then 
analyzed.  
Ethical clearance of this study was obtained from the 
Ethics Committee of the Faculty of Medicine, University of 
Padjadjaran. Secondary data was then taken from the 
Rheumatology Division of the Internal Medicine Department 
Dr. Hasan Sadikin Bandung. 
 
Result 
Eighty-eight patients met the inclusion criteria and were all 
included in this study. 
 
Table 1. SLE Patients Characteristics  
 Variables Cases N=88(%) 
Gender    
• Male 0 (0) 
• Female 88 (100) 
Age Groups   
• 18–24 years 8 (9,1) 
• 25–34 years 29 (33,0) 
• 35–44 years 25 (28,4) 
• 45–54 years 18 (20,5) 
• ≥55 years 8 (9,1) 
Duration of SLE   
• <1 year 0 (0) 
• 1-5 years 38 (43,2) 
• >5 years 50 (56,8) 
Total Cholesterol   
• <200 mg/dL 64 (72,7) 
• ≥200 mg/dL 24 (27,3) 
Low Density Lipoprotein (LDL)   
• <100 mg/dL 36 (40,9) 
• ≥100 mg/dL 52 (59,1) 
High Density Lipoprotein (HDL)   
• <40 mg/dL 4 (4,5) 
• ≥40 mg/dL 84 (95,5) 
Triglycerides   
• <150 mg/dL 75 (85,2) 
• ≥150 mg/dL 13 (14,8) 
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Table 1 shows the characteristics of the study subjects in 
terms of gender, age, and duration of SLE. Eighty-eight 
(100%) patients in this study were female. Most of the SLE 
patients in this study were in the age range of 25-34 years, 
comprised of 29 patients (33%) and most patients were found 
to have SLE for more than 5 years (56.8%). 
 
Table 2. Carotid Artery Atherosclerotic Plaque  
Characteristics in SLE Patients  
Category Cases N=88 (%) 
Atherosclerotic Plaque (n=88)  
No plaque found 78 (88,6) 
Plaque found 10 (11,4) 
Plaque Location (n=10)  
Left Carotid Artery 2 (20) 
Right Carotid Artery 5 (50) 
Both Arteries 3 (30) 
Table  2  provides  an  overview  of  the  presence  of 
atherosclerotic  plaque,  with  78 patients  (88.6%)  have 
no atherosclerotic plaque and 10 patients (11.4%) have 
atherosclerotic plaques. Table 2 points the location of 
atherosclerotic plaque, with 2 patients (20%) have 
atherosclerosis plaque in the left carotid artery, 5 patients 
(50%) have atherosclerotic plaque in the right carotid, and 3 
patients (30%) have atherosclerotic plaque in both the left 
carotid artery and in the right carotid artery. 
 
Table 3. Atherosclerotic Plaque Results by Age Group  
Age 
Atherosclerotic No Atherosclerotic 
Total 
Plaque Plaque   
18-24 years 0 (0) 8 (100) 8 (100) 
25-34 years 1 (3,4) 28 (96,5) 29 (100) 
35-44 years 4 (16) 21 (84) 25 (100) 
45-54 years 4 (22,2) 14 (77,7) 18 (100) 
>55 years 1 (12,5) 7 (87,5) 8 (100) 
 
Table 4. Atherosclerotic Plaque Results by Lipid Profiles  
 
Atherosclerotic 
No   
Category Atherosclerotic Total P-Value 
 Plaque Plaque   
    
Cholesterol     
<200 mg/dL 5 (7,8) 59 (92,2) 64 (100) 0.87 
≥200 mg/dL 5 (20,8) 19 (79,2) 24 (100)  
LDL     
<100 mg/dL 4 (11,1) 32 (88,8) 36 (100) 0.46 
≥100 mg/dL 6 (11,5) 46 (88,5) 52 (100)  
HDL     
<40 mg/dL 0 (0) 4 (100) 4 (100) 0.95 
≥40 mg/dL 10 (11,9) 74 84 (100)  
Triglycerides     
<150 mg/dL 8 (10,6) 67 75 (100) 0.62 
≥150 mg/dL 2 (15,3) 11 13 (100)  
 
Table 3 provides an overview of atherosclerotic plaques 
based on age groups. In the age group of 35-44 years, there 
were 4 patients (16%) with atherosclerotic plaque out of a total 
of 25 patients. In the 45-54 years age group, there were 
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4 patients (22.2%) with atherosclerotic plaque out of a total of 
18 patients, and 1 patient (12.5%) with atherosclerotic plaques 
were found in the >55 years age group from a total of 8 
patients.  
Table 4 provides an overview of atherosclerotic plaques 
based on lipid profiles (cholesterol, LDL, HDL, triglycerides). 
At the ≥ 200 mg/dL cholesterol level group there were 5 
patients (20.8%) with atherosclerotic plaque from a total of 24 
patients.  
At the ≥ 150 mg / dL triglyceride levels group there were 
2 patients (15.3%) with atherosclerotic plaque from a total of 
11 patients.  
Chi-square analysis test result on lipid profiles 
(cholesterol, LDL, HDL, triglycerides) was more than 0.05. 
This result indicates that the data was not significant. 
 
Discussion 
The patients in this study were found to be all female. This is 
in accordance with SLE research studies in Indonesia which 
has a 22:1 ratio between women and men.11 Results in this 
study showed that 10 patients (11.4%) has atherosclerotic 
plaque, which is the symptom of coronary artery disease 
(CAD). This is in accordance with previous studies on the 
prevalence of SLE patients with atherosclerotic plaque, ranges 
from 6.6% in the Pitsburg study9 to 8.3% from the Baltimore 
cohort study12. SLE patients with the highest number of 
atherosclerotic plaques were in the age range of 35-44 years 
(16%) and 45-54 years (22.2%). These results are in 
accordance with previous studies in the framingham off study, 
showing that SLE women with an age range of 35-44 years 
have a risk of getting myocardial infarction up to 50 times 
higher than non-SLE women with the same age range.9  
Clinical manifestations in patients with SLE are very diverse, 
one of which affects the cardiovascular system in the form of 
atherosclerotic plaque.2 The formation of atherosclerotic plaque 
in SLE patients is influenced by several factors. In this study there 
is a description of atherosclerotic plaque based on age and lipid 
profile (cholesterol, HDL, LDL, triglycerides. Results of 
atherosclerotic plaque based on cholesterol level groups shows 
that at normal cholesterol levels <200mg / dl there are 5 patients 
(7.8%) with plaque atherosclerosis, and at cholesterol levels 
≥200mg / dl there are 5 patients (20.8%) with atherosclerotic 
plaque. Some studies suggested that increased cholesterol levels 
can increase the risk of atherosclerotic plaque formation.13  
Results of atherosclerotic plaque based on LDL shows that 
there were 4 patients (11.1%) with normal LDL level (<100 
mg/dl) and had atherosclerotic plaque. There were 6 patients 
(11.5%) with increased LDL level (≥100 mg/dl) and had 
atherosclerotic plaque. Previous studies showed that higher 
LDL levels in a person will increase the risk of atherosclerotic 
cardiovascular disease.14  
Results of atherosclerotic plaque based on HDL shows that 
there were 0 patients (0%) with low HDL level (<40 mg/dl) and 
had atherosclerotic plaques. There were 10 patients (11.9%) with 
high HDL level (≥40 mg/dl) and had atherosclerotic plaques. 
Previous studies mentioned that HDL levels in the 
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body influences atherosclerotic plaque regression.15  
Results of atherosclerotic plaque based on triglycerides 
shows that there were 8 patients (10.6%) with normal levels of 
triglycerides (<150mg/dl) and had atherosclerotic plaques. There 
were 2 patients (15.3%) with high levels of triglycerides 
(≥150mg/dl) and had atherosclerotic plaques. Previous studies 
showed that high triglycerides level increases the risk of 
atherosclerosis formation and its development. Triglycerides 
were found to promote the formation of foam cells, and 
subsequently the development of atherosclerosis plaque.16  
Chi-square analysis test on all lipid profiles in this study 
was more than 0.05, indicating that the data is not significant. 
These findings can be caused by several factors, such as the 
small number of samples in this study and the non-traditional 
factors in the formation of atherosclerotic plaque as well as the 
traditional factors.  
The weakness of this study is the small number of samples, 
which causes the data to be insignificant when chi-square 
analysis test was performed. Other confounding factors need 
to be considered that can influence the result of this type of 
study. 
 
Conclusion 
The prevalence of carotid artery atherosclerosis plaque in 
patients with SLE in Dr. Hasan Sadikin General Hospital from 
2017 to 2018 is 11.4%. 
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